Attitudes of Portuguese health professionals toward adverse drug reaction reporting

International Journal of Clinical Pharmacy

Volumn 34, Issue 5, 2012, Pages 693-698

  Dos Santos Pernas, Sílvia Isabel ^a   Herdeiro, Maria Teresa ^a,b,c   Lopez Gonzalez, Elena ^d   Da Cruz E Silva, Odete A B ^a   Figueiras, Adolfo ^d,e  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b Polytechnic Health Institute of North   (Portugal)

^c University of Porto   (Portugal)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

ADR reporting; Adverse drug reactions; Health professionals; Pharmacovigilance; Portugal

Indexed keywords

ADULT; ARTICLE; CORRELATION COEFFICIENT; DRUG SURVEILLANCE PROGRAM; ETHNIC GROUP; FEMALE; HUMAN; MALE; NORMAL HUMAN; NURSE ATTITUDE; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PORTUGAL; PORTUGUESE; PRIORITY JOURNAL; REPRODUCIBILITY; STRUCTURED QUESTIONNAIRE; TEST RETEST RELIABILITY; VISUAL ANALOG SCALE;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; PHARMACOVIGILANCE; PILOT PROJECTS; PORTUGAL; QUESTIONNAIRES; YOUNG ADULT;

EID: 84867350337     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9675-6     Document Type: Article

References (22)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jr Am Med Assoc. 1998;279:1200-5.
2. Leendertse AJ, Visser D, Egberts A, van den Bemt PMLA. The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf. 2010;33(3):233-44.
3. WHO: Importance of Pharmacovigilance. Geneve: World Health Organization (2002). ISBN: 924-1590157.
4. Erill S. Avances en las técnicas de detección de reacciones adverses a los medicamentos. In: Laporte J, Salva JÁ, editors. Avances en terapéutica, vol. 5. Barcelona: Editorial Salvat; 1973, p. 124-48. ISBN: 978-84-97991-10-0.
5. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br J Clin Pharmacol. 1996;42:423-9.
6. Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. Br Med J. 1998;316:1295-8.
7. Vaz FICPR. Estratégias de combate à subnotificaç ão de Reacções Adversas a Medicamentos, Intervenç ão de reforço em profissionais de saúde através de entrevistas telefónicas e Workshops. Dissertação de Mestrado. In: Faculdade de Medicina, Universidade do Porto. (2009). http://repositorio-aberto.up.pt/bitstream/10216/21957/2/Dissertao.pdf.
8. Inman W. Assessment of drug safety problems. In: Gent M, Honolulu SI, editors. Epidemiological issues in reported druginduced illnesses. McMaster University Library Press: Honolulu; 1976; p. 17-24. ISBN: 0919592023.
9. Inman W, Weber JCT. The United Kingdom. In: Inman WHW, editor. Monitoring for drug safety, 2nd edn. Lancaster: MTP Press Ltd. 1986; p. 13-47. ISBN: 0852007213.
10. Inman W. Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol. 1996;41:433-5.
11. Figueiras A, Tato F, Fontaiñas J, Gestal-Otero JJ. Influence of physicians' attitudes on reporting adverse drug events: a casecontrol. Med Care. 1999;37(8):809-14.
12. Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825-33.
13. Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2006;29(4):331-40.
14. Green FC, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51:81-6.
15. Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, et al. Physician knowledge, attitudes and behaviour related to reporting adverse drug events. Arch Intern Med. 1988;148: 1596-600.
16. Scott HD, Thatcher A, Rosenbaum SE, Waters WJ, Green M. Adverse drug reaction reporting systems: the United Kingdom and the Unit States. R I Med J. 1988;71:179-84.
17. Backstrom M, Ekman E, Mjorndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol. 2007;63: 613-8.
18. Nickerson CAE. A note on 'A concordance correlation coefficient to evaluate reproducibility'. Biometrics. 1997;53(4): 1503-7.
19. Quinn C, Haber MJ, Pan Y. Use of the concordance correlation coefficient when examining agreement in dyadic research. Nurs Res. 2009;58(5):368-73.
20. Siegel S, Castellan NP. Nonparametric statistics for behavioral sciences, 2nd edn. USA: McGraw-Hill. 1988. ISBN 978-0070 573574.
21. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of underreporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19-31.
22. Russell VL. Some practical guidelines for effective sample size determination. Am Stat. 2001;55(3):187-93.